Double Medical Technology

Double Medical Technology Equity

The The Equity of Double Medical Technology (002901.SZ) as of Oct 18, 2026 is 3.57 B CNY. In the previous year, The Equity was 3.08 B CNY — a change of 15.95% (higher).

Equity

3.57 BCNY

YoY

15.95%

Last updated:

In 2025, Double Medical Technology's equity was 3.57 B CNY, a 15.95% increase from the 3.08 B CNY equity in the previous year.

The Double Medical Technology Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
1.44 B CNY
Jan 1, 2019
1.72 B CNY
Jan 1, 2020
2.10 B CNY
Jan 1, 2021
2.51 B CNY
Jan 1, 2022
3.00 B CNY
Jan 1, 2023
3.06 B CNY
Jan 1, 2024
3.08 B CNY
Jan 1, 2025
3.57 B CNY
The Double Medical Technology Equity history
YEAREquityYoY
3.57 BCNY+15.95%
3.08 BCNY+0.67%
3.06 BCNY+1.96%
3.00 BCNY+19.39%
2.51 BCNY+19.42%
2.10 BCNY+22.19%
1.72 BCNY+19.58%
1.44 BCNY+17.32%
1.23 BCNY+113.85%
573.90 MCNY+30.70%
439.10 MCNY+61.89%
271.24 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Double Medical Technology Stock analysis

What does Double Medical Technology do? Double Medical Technology Inc, listed on the Shenzhen Stock Exchange under ticker 002901.SZ, operates in the Health Care sector with a focus on medical consumables. Headquartered in Xiamen, China, the company employs 3,793 full-time staff. It completed its initial public offering (IPO) on September 22, 2017. Double Medical Technology engages in the production, research and development, and sale of medical consumables, including orthopedic trauma implant materials, spinal implant materials, and nerve surgical implant materials. The company also manufactures surgical instruments. Its products are distributed both domestically within China and internationally. The firm's website is http://www.double-medical.com/. As a publicly traded entity, it provides medical products essential for surgical procedures and patient care, operating within the healthcare industry framework. The company's operations are centered around the development and supply of specialized medical devices and consumables, targeting healthcare providers and institutions globally. Double Medical Technology maintains a presence in both domestic and international markets, reflecting its strategic approach to market expansion and product distribution. Double Medical Technology is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Double Medical Technology's Equity

Double Medical Technology's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Double Medical Technology's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Double Medical Technology's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Double Medical Technology's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Double Medical Technology’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Double Medical Technology stock

The Equity of Double Medical Technology is 3.57 B CNY in 2025.

The Equity of Double Medical Technology changed from 3.08 B CNY to 3.57 B CNY, representing a 15.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Double Medical Technology since 2006 – with annual values, charts, and detailed analysis.

The Equity's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Double Medical Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Double Medical Technology

All Key Metrics — Double Medical Technology